In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.
about
In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses.Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniaePostantibiotic suppression of growth of erythromycin A-susceptible and -resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens.In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancerIn vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus speciesIn vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanismsBinding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNAMacrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001.In vitro pharmacodynamics of the new ketolides HMR 3004 and HMR 3647 (Telithromycin) against Chlamydia pneumoniaeIn vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.Kinetic study of the inflammatory response in Streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004.
P2860
Q28344762-026974E0-F63C-41CB-AC73-250CCA3FCFEFQ30662421-1769D65E-0BC4-40B6-962D-B5100BE1BC70Q33181522-30134B8F-B0AE-4E84-B5E7-FF4CC783717BQ33971827-7AB4D6EE-1C4D-4C1E-9AA2-DBA7367A1217Q33978781-44C08789-F359-4CF3-BE95-C96CE69BCB7DQ33979896-EB7BD6B6-069A-4962-B5DA-6F9D34C22484Q33981093-A751CF76-7BC4-4482-BE4A-1603706D1CFCQ33981500-11320C9B-306D-4454-B706-A06DE9A57419Q33981631-10AA5190-EBD0-4045-B23D-90A4C761B16FQ33982849-D56E0E15-FEC2-4F25-9D24-BF096E3C525BQ33997135-4A64513B-C602-4A2E-A462-59B180AC0B7CQ34820774-8CDE68E5-FF39-47C0-984C-5A66E7772FC1Q37876245-8528C74B-8891-4713-9F52-8CBE834A7D02Q37876885-A45FF92E-89F4-4366-A87B-7CD469BC9C96Q39476004-1D09060C-79E4-4A93-BF03-9751B4BF4805
P2860
In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
In vitro activities of the new ...... ococcus pneumoniae in Germany.
@ast
In vitro activities of the new ...... ococcus pneumoniae in Germany.
@en
type
label
In vitro activities of the new ...... ococcus pneumoniae in Germany.
@ast
In vitro activities of the new ...... ococcus pneumoniae in Germany.
@en
prefLabel
In vitro activities of the new ...... ococcus pneumoniae in Germany.
@ast
In vitro activities of the new ...... ococcus pneumoniae in Germany.
@en
P2093
P2860
P356
P1476
In vitro activities of the new ...... tococcus pneumoniae in Germany
@en
P2093
A Bryskier
R Lütticken
R R Reinert
P2860
P304
P356
10.1128/AAC.42.6.1509
P407
P577
1998-06-01T00:00:00Z